Investor Relations

Latest Financial Results

Q2 2020

Quarter Ended Jun 30, 2020

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2019

Company Overview

SINTX Technologies is a commercial biomaterial company focused on using its silicon nitride technology platform to develop, manufacture and sell a broad range of medical devices. SINTX markets spinal fusion products and is developing a new generation of orthopaedic bearings for hip and knee arthroplasty. The company operates an ISO 13485 certified manufacturing facility and its spine products are FDA registered and ISO 13485:2016 certified, CE marked, and currently marketed in the U.S. and select markets in Europe and South America.

Investor Contact Information

Company

SINTX Technologies, Inc.
1885 West 2100 South
Salt Lake City, UT 84119
T: 855.839.3500

Investor Relations

T: 801-839-3502
IR@sintx.com

Transfer Agent

American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
T: 718-921-8124
www.amstock.com

Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.